|

Retatrutide Clinical Trials

2 actively recruiting trials across 1 location

▼ -1 trial since June 2026

Also known as: LY3437943

Pipeline

Phase 1: 1Phase 3: 1

Top Sponsors

  • Eli Lilly and Company2

Indications

  • Liver Disease1
  • Insulin Sensitivity1
  • Metabolic Dysfunction-Associated Steatotic Liver Disease1
  • Diabetes Mellitus1
  • Diabetes1

Other1 trial

A Study to Evaluate the Effect of Retatrutide on Insulin Secretion and Insulin Sensitivity in Adult Participants With Type 2 Diabetes Mellitus
Phase 1

Tuscaloosa, Alabama1 trial

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

MFA Clinical Research

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.